Drug Profile
SUN 1334H
Alternative Names: SUN 1334; SUN-1334HLatest Information Update: 22 Nov 2016
Price :
$50
*
At a glance
- Originator Sun Pharmaceutical Industries
- Class Antiallergics; Antihistamines
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Allergic conjunctivitis; Chronic urticaria; Perennial allergic rhinitis; Seasonal allergic rhinitis
Most Recent Events
- 24 Aug 2011 Phase-I/II clinical trials in Perennial allergic rhinitis in India (Intranasal)
- 24 Aug 2011 Phase-I/II clinical trials in Seasonal allergic rhinitis in India (Intranasal)
- 30 Jun 2011 Phase-II clinical trials in Allergic conjunctivitis in USA (Ophthalmic)